NCT07412119Not yet recruiting
Research on Disease Control and Mental Health Status of Adolescent Asthma Patients
Source: ClinicalTrials.gov · Last updated 17 Feb 2026
Brief summary (registry, in English)
Background: Currently in China, adolescent asthma care is characterized by both undertreatment and overtreatment. Patients in this age group may exhibit negative emotions toward disease treatment and long-term control. Insufficient disease knowledge, irregular lifestyle habits, and negative attitudes toward the disease can all reduce medication adherence, affect disease control outcomes, and thereby increase the risk of severe chronic respiratory conditions and disease burden in adulthood. Objectives: To assess disease control status in adolescent asthma patients, evaluate the psychological well-being of patients and their family members, and understand patients' self-management skills and readiness for transition to adulthood. Procedures: Eligible participants will complete a series of assessment questionnaires through the Youran Huxi mobile application, including questionnaires on asthma control, physical activity, psychological health, self-management behaviors, and transition readiness. The study period is 12 months; the baseline assessment involves one-time completion of written questionnaires with no interim follow-up visits. The study does not intervene in clinical diagnosis or treatment decisions.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 460 (estimated)
- First submitted
- 6 Feb 2026
- Start date
- 1 Apr 2026
- Primary completion date
- 1 Oct 2027
- Lead sponsor
- Beijing Children's Hospital
- Diseases
- Asthma
- NCT number
- NCT07412119
What you commit to
- Study type: Observational
- Planned participants: 460
- From 1 Apr 2026 to the primary completion date, 1 Oct 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Children with other respiratory diseases such as bronchiectasis, bronchiolitis, cystic fibrosis and pneumonia
- Combined with chronic diseases of other systems
Who the study is looking for
- Meet the asthma diagnostic criteria of GINA 2025
- Age 12 to 18 years old
- The parents and the child patient agreed and filled out the questionnaire completely.
Age in the registry: 12 years to 18 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.